Pfizer Japan has launched TicoVac®, the country’s first approved vaccine to prevent Tick-Borne Encephalitis (TBE), available in adult (0.5mL) and pediatric (0.25mL) formulations. TBE is a serious viral infection transmitted by ticks, with symptoms ranging from fever and headache to severe neurological issues. The Far Eastern subtype, found in Hokkaido, has a fatality rate over 20%, with long-term complications in many survivors.

While previously rare in Japan, recent cases in Hokkaido and antibody findings in multiple prefectures suggest the virus may be more widespread. Limited awareness and testing may mean many cases go undiagnosed.

TicoVac® has been used safely in Europe since the 1970s and was officially approved in Japan in March 2024. It is recommended for residents in at-risk regions and travelers to endemic areas. Contact us to learn more or schedule your vaccination.

*Three doses and 5-12 months will be needed to complete the initial series.

Our clinic offers Multiple Drug Urine Testing using a single urine sample to quickly and efficiently screen for a wide range of substances. Known as a “panel test,” this method can detect multiple drugs simultaneously, including amphetamines, cocaine, opiates, marijuana, benzodiazepines, and barbiturates. Rapid results are available for initial screenings.

This comprehensive screening covers substances such as Marijuana (THC – also known as weed, pot, dope), Cocaine (COC), Opiates (OPI 2000), Amphetamines (AMP), Barbiturates (BAR), Benzodiazepines (BZO), Ecstasy (MDMA), Methamphetamine (MET/mAMP), Methadone (MTD), Oxycodone (OXY), Phencyclidine (PCP), and Propoxyphene (PPX). It is an essential tool for medical evaluations, workplace screenings, and personal health assessments. For accurate and confidential testing, please contact our clinic to learn more or schedule an appointment.

HEALTH IMMUNIZATION CLEARANCE DONE HERE ~ We will help you with your proof of immunization for college and university, even if it is written in Japanese. Please send us a copy of the requirements and all vaccination records in advance.

留学、渡航、海外赴任を準備されている方、必要な予防接種の相談を承ります。ものによっては時間がかかるものもありますので早めに電話03-6441-0969やメールinfo@americanclinictokyo.comにてご相談ください。

相談料は無料。YellowBook（接種証明）および海外赴任ガイドも贈呈中。問診および診察料はワクチン価格に含まれます。母子手帳を英文に書き直す作業は有料で行います。

A Study on the Synchronization of Music and Breath

COVID-19 Test Appointments: Reserve your spot by completing this form –

https://docs.google.com/forms/d/e/1FAIpQLSe9GvGkKu3IxlOA-zSfBmOp8iQtYoLN3ZYEs3c9V78-hkO6qg/viewform?usp=sf_link

Our team will promptly reach out to confirm your appointment.

Antigen Test (Lateral flow) – All-inclusive price of 15000 yen for the test, consumption tax, English certificate, and consultation. This test will be conducted via nasal swab and will take 15 minutes to process. You will be leaving with a physician-signed document in hand.

PCR Test (Real-time Reverse Transcription) – All-inclusive price of 25000 yen for the test, consumption tax, English certificate, and consultation. This test will be conducted via saliva (or nasopharyngeal swab if required). Samples received by 12:00 noon will be processed by 18:00. Samples received in the afternoon will be processed by 9:00 the following business day. You will be receiving a PDF via email as soon as the laboratory report is ready. This test can be used to shorten the quarantine period when entering Japan.

Japan National Tourism Organization (JNTO) operates a visitor hotline 24 hours a day, 365 days a year. Call for tourist information or assistance in the case of accidents and emergencies including novel coronavirus(COVID-19). Support is available in English, Chinese, Korean and Japanese.

• JAPAN VISITOR HOTLINE 050-3816-2787
• IF CALLING FROM OVERSEAS +81-50-3816-2787

Shingles is a painful rash caused by reactivation of the chickenpox virus. 99% of people over 50 years of age are living with the virus that causes shingles. One in three people will develop shingles in their lifetime.

SHINGRIX works to boost your body’s protection against shingles (herpes zoster). It is a FDA-approved 2-dose series proven to be up to 90% effective in clinical trials.

It is given as a two-dose series, two months apart.

For more information please follow this link: https://www.cdc.gov/vaccines/hcp/vis/vis-statements/shingles-recombinant.pdf

If you wish to proceed, please sign up here: https://forms.gle/ehw9ojPrQemcg7bP7